11/11/2024

Rocuronium Injection

Products Affected - Description

- Rocuronium Bromide solution for injection, Hikma, 10 mg/mL, 10 mL vial, 10 count, NDC 00143-9251-10
- Rocuronium Bromide solution for injection, Hikma, 10 mg/mL, 5 mL vial, 10 count, NDC 00143-9250-10

Reason for the Shortage

- Baxter has rocuronium injection available.
- Eugia has rocuronium injection available.
- Fresenius Kabi has rocuronium injection available.
- Hikma has rocuronium injection on shortage due to increased demand.
- Meitheal has rocuronium injection available.
- Pfizer has rocuronium injection available.
- Piramal Critical Care has rocuronium injection available.
- Sagent has launched new NDCs and product is available.
- Sandoz did not provide a reason for the shortage.
- Viatris did not provide a reason for the shortage.
- X-Gen has rocuronium injection available.

Available Products

- Rocuronium Bromide solution for injection, Baxter, 10 mg/mL, 10 mL vial, 10 count, NDC 43066-0013-10
- Rocuronium Bromide solution for injection, Baxter, 10 mg/mL, 5 mL vial, 10 count, NDC 43066-0007-10
- Rocuronium Bromide solution for injection, Eugia US, 10 mg/mL, 10 mL vial, 10 count, NDC 55150-0226-10
- Rocuronium Bromide solution for injection, Eugia US, 10 mg/mL, 5 mL vial, 10 count, NDC 55150-0225-05
- Rocuronium Bromide solution for injection, Fresenius Kabi, 10 mg/mL, 10 mL vial, 10 count, NDC 63323-0426-10
- Rocuronium Bromide solution for injection, Fresenius Kabi, 10 mg/mL, 5 mL RFID vial, 10 count, NDC 65219-0065-05
- Rocuronium Bromide solution for injection, Fresenius Kabi, 10 mg/mL, 5 mL vial, 10 count, NDC 63323-0426-05
- Rocuronium Bromide solution for injection, Meitheal Pharmaceuticals, 10 mg/mL, 10 mL vial, 10 count, NDC 71288-0718-11
- Rocuronium Bromide solution for injection, Meitheal Pharmaceuticals, 10 mg/mL, 5 mL vial, 10 count, NDC 71288-0700-06
- Rocuronium Bromide solution for injection, Mylan Institutional (Viatris), 10 mg/mL, 10 mL vial, 10 count, NDC 67457-0228-10
- Rocuronium Bromide solution for injection, Mylan Institutional (Viatris), 10 mg/mL, 5 mL vial, 10 count, NDC 67457-0228-05
- Rocuronium Bromide solution for injection, Pfizer, 10 mg/mL, 10 mL vial, 10 count, NDC 00409-7037-10
- Rocuronium Bromide solution for injection, Pfizer, 10 mg/mL, 5 mL vial, 10 count, NDC 00409-3189-10
- Rocuronium Bromide solution for injection, Piramal Critical Care, 10 mg/mL, 10 mL vial, 10 count, NDC 66794-0229-41
- Rocuronium Bromide solution for injection, Piramal Critical Care, 10 mg/mL, 5 mL vial, 10 count, NDC 66794-0228-41
- Rocuronium Bromide solution for injection, Sagent, 10 mg/mL, 10 mL vial, 10 count, NDC 25021-0687-10
- Rocuronium Bromide solution for injection, Sagent, 10 mg/mL, 5 mL vial, 10 count, NDC 25021-0687-05
- Rocuronium Bromide solution for injection, Sandoz, 10 mg/mL, 10 mL vial, 10 count, NDC 00781-3220-92
- Rocuronium Bromide solution for injection, Sandoz, 10 mg/mL, 5 mL vial, 10 count, NDC 00781-3220-95
- Rocuronium Bromide solution for injection, X-Gen, 10 mg/mL, 10 mL vial, 10 count, NDC 39822-4200-06
- Rocuronium Bromide solution for injection, X-Gen, 10 mg/mL, 5 mL vial, 10 count, NDC 39822-4200-02

Estimated Resupply Dates

- Hikma has rocuronium 10 mg/mL 5 mL and 10 mL vials on allocation.

Updated

Updated November 11, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 9, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.